Performance, transparency, trust

We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page. 


Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site. 

Read our latest regulatory news

Observe Medical ASA: Interim report third quarter 2020

Oslo, November 3rd, 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes…

Read more

Observe Medical ASA : Invitation to third quarter 2020 presentation

Observe Medical ASA invites you to a presentation of the third quarter 2020. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, November 3. The event will start at 08.30 CET and will be webcasted live on – Investor relations and on the following link:!/hegnarmedia/20201103_4 Due to COVID-19 and corresponding…

Read more

Financial calendar

  • 23.02.21

    Quarterly Presentation – Q4

  • 30.04.21

    Annual Report

  • 12.05.21

    Quarterly Presentation - Q1

  • 21.05.21

    Annual General Meeting

  • 20.08.21

    Half-yearly Report

  • 03.11.21

    Quarterly Presentation - Q3

The Share

Share performance


Last updated 31 December 2020

NameNumber of shares% of top 20% of totalCountry
1NAVAMEDIC ASA 4,222,727  25.70%21.54%Norway
2INGERØ REITEN INV. COMPANY AS 3,939,394  23.98%20.09%Norway
3RO, LARS 1,500,000  9.13% 7.65%NORWAY
5ARTAL AS 897,407 5.46% 4.58%Norway
6ALPINE CAPITAL AS 650,000 3.96% 3.32%Norway
7Soleglad Invest AS 586,668 3.57% 2.99%NORWAY
8NORDA ASA 516,570  3.14% 2.63%Norway
9TRANBERGKOLLEN INVEST AS 500,000  3.04% 2.55%Norway
10LEIKERANE AS 466,666  2.84% 2.38%Norway
11LAPAS AS 336,924 2.05% 1.72%Norway
12MP PENSJON PK 262,025  1.59% 1.34%NORWAY
14BUKKEVIK INVESTERING AS 140,160 0.85% 0.71%norway
15GINNY INVEST AS 140,000 0.85% 0.71%Norway
16Bjørntvedt, vegard 136,358 0.83% 0.70%Norway
17BJØRNTVEDT, EIVIND 130,000 0.79% 0.66%norway
18NORDNET BANK AB 125,572 0.76% 0.64%sweden
19philip invest as 125,000 0.76% 0.64%Norway
20ABC INVEST AS 120,000 0.73% 0.61%norway
Total numBer owned by top 2016,430,843100.00%83.81%
Total number of shares19,605,457

Basic share data

Stock Exchange:


First day of listing:


Trading Currency:


Number of shares issued:

Nominal value:

Euronext Expand Oslo


4 November 2019




19 605 457

NOK 0.26


Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these. 

For nomination committee please contact: 

Björn Larsson, Chief Executive Officer
+46 766 201 725 /

IR contact

Björn Larsson, Chief Executive Officer
+46 766 201 725 /

Per Arne Nygård, Chief Financial Officer
+47 41 10 43 45 /

Sign up for the mailing list